Interestingly, proprotein convertase subtilisin/kexin type-9 (PCSK-9) (a regulator of LDLR) expression in cancer cells is found to be much lower expressed than their non-cancerous counterparts (Bhat et al., 2015). Here, PCSK9 is linked to cancer.